GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cresco Labs Inc (XCNQ:CL) » Definitions » Enterprise Value

Cresco Labs (XCNQ:CL) Enterprise Value : C$1,255.2 Mil (As of Dec. 12, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Cresco Labs Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cresco Labs's Enterprise Value is C$1,255.2 Mil. Cresco Labs's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 was C$79.0 Mil. Therefore, Cresco Labs's EV-to-EBIT ratio for today is 15.89.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Cresco Labs's Enterprise Value is C$1,255.2 Mil. Cresco Labs's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was C$176.9 Mil. Therefore, Cresco Labs's EV-to-EBITDA ratio for today is 7.09.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Cresco Labs's Enterprise Value is C$1,255.2 Mil. Cresco Labs's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was C$998.2 Mil. Therefore, Cresco Labs's EV-to-Revenue ratio for today is 1.26.


Cresco Labs Enterprise Value Historical Data

The historical data trend for Cresco Labs's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresco Labs Enterprise Value Chart

Cresco Labs Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,414.12 3,238.67 3,006.50 1,432.85 1,281.16

Cresco Labs Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,601.57 1,281.16 1,609.83 1,397.31 1,386.01

Competitive Comparison of Cresco Labs's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Cresco Labs's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cresco Labs's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cresco Labs's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Cresco Labs's Enterprise Value falls into.



Cresco Labs Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Cresco Labs's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Cresco Labs's Enterprise Value for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cresco Labs  (XCNQ:CL) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Cresco Labs's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1255.214/79.007
=15.89

Cresco Labs's current Enterprise Value is C$1,255.2 Mil.
Cresco Labs's EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$79.0 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Cresco Labs's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=1255.214/176.923
=7.09

Cresco Labs's current Enterprise Value is C$1,255.2 Mil.
Cresco Labs's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$176.9 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Cresco Labs's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=1255.214/998.195
=1.26

Cresco Labs's current Enterprise Value is C$1,255.2 Mil.
Cresco Labs's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$998.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cresco Labs Enterprise Value Related Terms

Thank you for viewing the detailed overview of Cresco Labs's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cresco Labs Business Description

Traded in Other Exchanges
Address
400 West Erie Street, Suite 110, Chicago, IL, USA, 60654
Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and others. The Company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.